TRANYLCYPROMINE SULFATE
Tranylcypromine Sulfate is indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants. Tranylcypromine…
Medications Updated During May 2022, From Oldest to Newest, Page 30
Ultomiris (Ravulizumab)
ULTOMIRIS is a complement inhibitor indicated for: the treatment of adult and pediatric patients one month of age and older with paroxysmal nocturnal hemoglobinuria (PNH) (1.1). the…
Acetazolamide
For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma,…
DRAXIMAGE DTPA (Kit For the Preparation of Technetium Tc 99m Pentetate)
DRAXIMAGE DTPA, after radiolabeling with Technetium Tc 99m, is indicated for DRAXIMAGE DTPA is a kit for the preparation of Technetium Tc 99m pentetate injection. Technetium Tc 99m…
Dutasteride
Dutasteride is a 5 alpha-reductase inhibitor indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: (1.1). improve symptoms,…